Ginkgo Datapoints partners with TuneLab to accelerate AI drug discovery
The agreement provides Ginkgo's biological data generation services to the platform, integrating lab automation with AI models for faster therapeutic development.
See the latest news and media coverage for Ginkgo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Autonomous lab platform for biotechnology R&D
ginkgo.bioLast updated
In short: Ginkgo posted a 48% Q2 revenue drop to $20M while expanding autonomous labs to Novo Nordisk and four universities.
The agreement provides Ginkgo's biological data generation services to the platform, integrating lab automation with AI models for faster therapeutic development.
The partnership expands Ginkgo's role as a provider of automation tools and software for U.S. R&D, reflecting industry momentum toward autonomous labs.
Revenue fell 48% to $20 million, and Ginkgo will build autonomous labs for MIT, Caltech, Northwestern, and University of Maryland.
Its autonomous lab pairs frontier models with lab infrastructure to speed experimentation and cut costs.
On September 16, 2026, Twist Bioscience Corp (TWST) and Ginkgo Bioworks (DNA) gained momentum following their strategic partnership with Eli Lilly's...
The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $7.14 / share from $9.18 on August 25, 2026, a decrease...
Twist Bioscience (TWST) stock and Ginkgo Bioworks (DNA) stock gain as companies ink agreements with Eli Lilly’s (LLY) TuneLab ...
Ginkgo Bioworks has been selected to build an autonomous laboratory at Novo's new research and development site in Waltham, Massachusetts, expanding a multi-year relationship between...
Track Ginkgo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.